Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-18-029650)

Filing Details

Accession Number:: 0000899243-18-029650
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-26 16:58:17
Reporting Period:: 2018-11-21

Accepted Time:: 2018-11-26 16:58:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1325879	Aveo Pharmaceuticals Inc	AVEO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1239241	B Anthony Evnin	C/O Aveo Pharmaceuticals, Inc. One Broadway, 14Th Floor Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-11-21	109	$2.05	109	No	4	P	Indirect	By Fund

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Fund

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	418,414	Direct

Footnotes

Consists of shares of common stock purchased by VEF Management III, LLC, or VEFM III. Dr. Evnin is a Member of VEFM III. Dr. Evnin expressly disclaims beneficial ownership over all shares held by or on behalf of VEFM III, except to the extent of his indirect pecuniary interest therein.